Northern General Hospital
Sheffield S5 7AU
7 studies enrolling now · 29 studies all time
What they study most
Acute Myocardial Infarction, Acute Myocardial Infarction (AMI), Atherosclerosis of Native Arteries of the Extremities, Unspecified, Atrial Fibrillation, Autosomal Dominant Polycystic Kidney Disease (ADPKD), Bronchiectasis, C. Diff Infection, C.Difficile Diarrhea, CDI, Cardiac Resynchronization Therapy, Cardiovascular Disease, Cardiovascular Risk
Studies at this site
- The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis — Recruiting now
- A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases — Recruiting now
- A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure — Recruiting now
- A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy — Recruiting now
- VE303 for Prevention of Recurrent Clostridioides Difficile Infection — Recruiting now
- ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack — Recruiting now
- A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB — Recruiting now
- Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH) — Running, not enrolling
- Phase 2a Study of VX-407 in Participants With ADPKD Who Have a Subset of PKD1 Gene Variants (AGLOW) — Running, not enrolling
- Selatogrel Outcome Study in Suspected Acute Myocardial Infarction — Enrolling by invitation
- Polycystic Kidney Disease 1 (PKD1) Gene Variant Groups in Autosomal Dominant Polycystic Kidney Disease — Running, not enrolling
- F15 Recharge Free Axonics SNM System Clinical Study — Running, not enrolling
- A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation — Running, not enrolling
- A Study of Ponsegromab in People With Heart Failure — Stopped early
- HEAL-IST IDE Trial — Running, not enrolling
- EMPA-KIDNEY (The Study of Heart and Kidney Protection With Empagliflozin) — Completed
- HbA1c Variation Study — Completed
- Understanding Outcomes With the EMBLEM™ S-ICD in Primary Prevention Patients With Low Ejection Fraction — Completed
- Early Use of Cryoprecipitate With Major Hemorrhage Protocol (MHP) Activation — Completed
- Study to Assess Efficacy and Safety of Cx601, Adult Allogeneic Expanded Adipose-derived Stem Cells (eASC) for the Treatment of Complex Perianal Fistula(s) in Participants With Crohn's Disease (CD) — Completed
- Precision Event Monitoring for Patients With Heart Failure Using HeartLogic — Completed
- A Clinical Study to Test How Effective and Safe GLPG1690 is for Subjects With Idiopathic Pulmonary Fibrosis (IPF) When Used Together With Standard of Care — Stopped early
- Efficacy and Safety of Nintedanib Co-administered With Sildenafil in Idiopathic Pulmonary Fibrosis Patients With Advanced Lung Function Impairment — Completed
- The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UTTR1147A in Participants With Neuropathic Non-Healing Diabetic Foot Ulcers — Completed
- Study of the Efficacy and Safety of Tezosentan in Patients With Pre-operative Pulmonary Hypertension, Due to Left Heart Disease, Undergoing Open Heart Surgery — Stopped early
- SuperNOVA Clinical Stenting Trial — Completed
- Study of a Clostridium Difficile Toxoid Vaccine (ACAM-CDIFF™) in Subjects With Clostridium Difficile Infection — Completed
- Ulimorelin Study of Efficacy and Safety (ULISES 007) — Completed
- Phase III Study to Investigate the Safety and Efficacy of Fermagate and Sevelamer Hydrochloride — Stopped early